Germany is trying to stop the US, which wants to persuade a German coronavirus vaccine company to transfer its research to the United States. This prompts German politicians to insist that no country should have a monopoly on any future vaccine.

The German health ministry has confirmed information that President Donald Trump has offered financial assistance to attract CureVac to the US, and the German government is making counter proposals to tempt the company to stay.

“The German government is keen to ensure that vaccines and active substances for the new coronavirus are being developed in Germany and Europe”, said the health ministry official. “In this regard, the government is in intense talks with CureVac”, added he.

A spokesman for the German Ministry of Health has confirmed the information.

For its part, the newspaper cites an anonymous government source who says Trump is trying to secure exclusive scientific work and would do anything to get the vaccine for the United States, “only for the United States”.

The US Embassy in Berlin did not immediately respond to a request for comment today in connection with the article. No one was online for CureVac’s comment. Welt am Sonntag claims that CureVac has refused to speak on the matter.

CureVac’s website reveals that Daniel Menichella’s chief executive met with Donald Trump earlier this month, with Vice President Mike Pence, members of the White House group responsible for coronavirus issues, and representatives senior management of pharmaceutical and biotech companies to discuss vaccine.